{"gene":"NR4A2","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":2009,"finding":"Nurr1 inhibits pro-inflammatory gene expression in microglia and astrocytes by docking to NF-κB-p65 on target inflammatory gene promoters in a signal-dependent manner, then recruiting the CoREST corepressor complex, resulting in clearance of NF-κB-p65 and transcriptional repression, thereby protecting dopaminergic neurons from inflammation-induced death.","method":"ChIP, co-immunoprecipitation, reporter assays, siRNA knockdown, primary cell culture, conditional knockout mice","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (ChIP, Co-IP, reporter assays, genetic KO) with clear mechanistic dissection in a highly-cited study","pmids":["19345186"],"is_preprint":false},{"year":2020,"finding":"Prostaglandin E1 (PGE1) and its metabolite PGA1 directly bind the ligand-binding domain (LBD) of Nurr1; PGA1 forms a covalent Michael adduct with Cys566 and induces a 21° conformational shift of the activation function-2 helix (H12), activating Nurr1 transcriptional function in a Nurr1-dependent manner.","method":"X-ray crystallography (2.05 Å), biophysical binding assays, mutagenesis, cell-based reporter assays, in vivo MPTP mouse model","journal":"Nature chemical biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with covalent adduct confirmed, mutagenesis, and functional validation in cells and in vivo","pmids":["32451509"],"is_preprint":false},{"year":2019,"finding":"The dopamine metabolite 5,6-dihydroxyindole (DHI) binds directly to the Nurr1 LBD within a non-canonical pocket, forming a covalent adduct with Cys566, and stimulates Nurr1 transcriptional activity including target genes underlying dopamine homeostasis.","method":"X-ray crystallography, biophysical binding assays, cell-based reporter assays, zebrafish model","journal":"Cell chemical biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure, covalent adduct confirmed, functional validation in cells and zebrafish","pmids":["30853418"],"is_preprint":false},{"year":2018,"finding":"The canonical ligand-binding pocket of Nurr1 LBD, although collapsed in crystal structures, is dynamic and exchanges between conformations on the microsecond-to-millisecond timescale, with high solvent accessibility that permits binding of unsaturated fatty acids.","method":"Solution NMR spectroscopy, hydrogen/deuterium exchange mass spectrometry, molecular dynamics simulations","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 — multiple biophysical methods including NMR, HDX-MS, and MD simulations convergently defining LBP dynamics","pmids":["30416039"],"is_preprint":false},{"year":2006,"finding":"The Nurr1 LBD lacks a canonical co-activator-binding site but possesses an alternative hydrophobic surface on the opposite side from the classical site; site-directed mutagenesis of this region abolished or altered transcriptional activity, and Nurr1 LBD activity correlates with proteasome-dependent degradation.","method":"Crystal structure analysis, site-directed mutagenesis, transcriptional reporter assays, proteasome inhibitor experiments","journal":"Journal of molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1-2 — structural analysis combined with mutagenesis and functional assays identifying a novel co-activator interaction surface","pmids":["17032747"],"is_preprint":false},{"year":2019,"finding":"Structural and biochemical analyses of NR4A2 DNA-binding domain (DBD) bound to Nur-responsive elements (NurREs) at 2.6-2.8 Å resolution revealed that two NR4A2-DBD molecules form a novel dimer interface on an inverted repeat element, and mutation of the interfacial residue V298K or DNA bases involved in the interaction abolished dimerization.","method":"X-ray crystallography, mutagenesis, biochemical DNA-binding assays, bioinformatics","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structures with mutagenesis validation defining the molecular basis of NR4A2 dimerization on DNA","pmids":["31723028"],"is_preprint":false},{"year":2011,"finding":"Nr4a2 directly binds regulatory regions of the Foxp3 locus and mediates permissive histone modifications, inducing Foxp3 expression and Treg differentiation; Nr4a2 deletion in T cells attenuates Treg induction and causes aberrant Th1 induction.","method":"ChIP, ectopic expression, siRNA knockdown, conditional T cell-specific knockout mice, in vitro suppression assays, colitis model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — ChIP confirming direct binding, genetic knockout with defined cellular phenotypes, multiple orthogonal methods","pmids":["21468021"],"is_preprint":false},{"year":2008,"finding":"NR4A2 augments promoter activities of IL-17 and IFN-γ genes in pathogenic T cells, and siRNA-mediated knockdown of NR4A2 significantly reduces IL-17 and IFN-γ production and attenuates the ability of encephalitogenic T cells to transfer EAE.","method":"Promoter-luciferase reporter assays, forced expression, siRNA knockdown, EAE adoptive transfer model","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — reporter assays plus in vivo adoptive transfer experiments with defined mechanistic readout","pmids":["18550828"],"is_preprint":false},{"year":2013,"finding":"NR4A2 controls full Th17 differentiation via autocrine IL-21 signaling; NR4A2 knockdown prevents IL-17 and IL-21 production and reduces IL-23R expression, and the differentiation defect is rescued by exogenous IL-21.","method":"siRNA knockdown, in vitro Th17 differentiation assays, cytokine rescue experiments, in vivo siRNA treatment in EAE model","journal":"PLoS ONE","confidence":"High","confidence_rationale":"Tier 2 — epistatic rescue experiment plus in vivo validation placing NR4A2 upstream of IL-21 autocrine loop in Th17 differentiation","pmids":["23437182"],"is_preprint":false},{"year":2003,"finding":"Nurr1 directly regulates dopamine synthesis and storage in MN9D dopamine cells by increasing expression of aromatic L-amino acid decarboxylase (AADC) and vesicular monoamine transporter-2 (VMAT2); VMAT2 upregulation requires continuous Nurr1 expression, and AADC and VMAT2 are deregulated in midbrain DA cells of Nurr1 knockout embryos.","method":"Inducible Nurr1 cell line, DA content measurement, in situ hybridization in knockout embryos","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 2 — inducible expression system combined with knockout validation demonstrating direct instructive role","pmids":["12915123"],"is_preprint":false},{"year":2004,"finding":"Nurr1 directly transactivates the osteocalcin (Ocn) gene in osteoblasts by binding as a monomer to an NBRE-like site in the proximal Ocn promoter; endogenous Nurr1 binds this site in chromatin immunoprecipitation assays, and mutation of the NBRE-like site abolishes Nurr1-dependent promoter activation.","method":"EMSA, ChIP, luciferase reporter assays with deletion/mutation analysis, adenoviral Nurr1 overexpression in primary osteoblasts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — EMSA, ChIP, and mutagenesis converging on direct transcriptional activation","pmids":["15485875"],"is_preprint":false},{"year":2012,"finding":"Nurr1 directly regulates Pitx3 expression in dopaminergic neurons by binding to a non-canonical NBRE consensus sequence 5' of the Pitx3 gene; deletion of this sequence abolishes Nurr1-driven reporter expression, and direct Nurr1-Pitx3 promoter interaction was confirmed in dopaminergic cell cultures and embryonic midbrain tissue by ChIP.","method":"Reporter assays with deletion/mutation analysis, ChIP in cell cultures and embryonic tissue, dose-dependent overexpression","journal":"PLoS ONE","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP in vivo plus mutagenesis of binding site demonstrating direct regulation","pmids":["22363463"],"is_preprint":false},{"year":2010,"finding":"Nurr1 regulates RET expression in adult rat midbrain dopaminergic neurons; adeno-associated vector-delivered anti-Nurr1 ribozyme knockdown reduces RET mRNA by ~77% and RET protein by ~47% in the substantia nigra; Nurr1 induces RET promoter transcription in a cell-type and concentration-dependent manner independent of NBRE elements.","method":"AAV-delivered ribozyme knockdown in vivo, qRT-PCR, microdialysis, reporter assays in cell lines","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo knockdown with mRNA and protein measurements, plus promoter reporter assays; single lab study","pmids":["20533997"],"is_preprint":false},{"year":2009,"finding":"Nurr1 interacts with p53 and represses its transcriptional assembly and activity in an interaction-dependent, dose-dependent manner; Nurr1 overexpression decreases Bax expression and protects cells from doxorubicin-induced apoptosis.","method":"Co-immunoprecipitation, reporter assays, siRNA knockdown, overexpression, apoptosis assays","journal":"Molecular cancer research","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP demonstrating interaction plus functional reporter and apoptosis assays; single lab study","pmids":["19671681"],"is_preprint":false},{"year":2015,"finding":"NR4A2 (Nurr1) transcriptionally activates arginase 1 expression by directly binding to its promoter in macrophages, and NR4A2 expression induced by TLR ligands (via PI3K-Akt signaling) promotes alternative (M2) macrophage polarization.","method":"ChIP, luciferase reporter assays, forced expression, siRNA knockdown, flow cytometry, adoptive transfer sepsis model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — ChIP confirming direct promoter binding plus in vivo adoptive transfer with defined mechanistic pathway","pmids":["25953901"],"is_preprint":false},{"year":2014,"finding":"PTH increases Nurr1 mRNA/protein levels prior to FGF23 induction; Nurr1 is essential for PTH-mediated FGF23 transcription and binds directly to functional Nurr1 binding sites in the FGF23 promoter as confirmed by ChIP in osteoblast-like cells.","method":"ChIP, luciferase reporter assays, siRNA knockdown, in vivo CKD rat model, immunohistochemistry","journal":"Kidney international","confidence":"High","confidence_rationale":"Tier 2 — ChIP confirming direct promoter binding, siRNA knockdown, and in vivo validation in disease model","pmids":["24940803"],"is_preprint":false},{"year":2011,"finding":"NR4A2 directly transactivates the proximal MMP-13 promoter via its DNA binding domain; NR4A2 overexpression in synoviocytes promotes proliferation, survival, anchorage-independent growth, migration, and invasion; a DNA-binding domain point mutation abolishes MMP-13 transcriptional activation.","method":"Stable overexpression, lentiviral shRNA knockdown, luciferase reporter assays with mutation analysis, proliferation and invasion assays","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis of DNA-binding domain combined with multiple functional assays clearly placing NR4A2 as direct MMP-13 transactivator","pmids":["22275273"],"is_preprint":false},{"year":2011,"finding":"PGE2-induced NR4A2 increases fatty acid oxidation in colorectal cancer cells by inducing multiple FAO pathway genes via direct binding to Nur77-binding response elements (NBREs) in their regulatory regions, with concomitant recruitment of transcriptional coactivators.","method":"ChIP, NBRE reporter assays, siRNA knockdown, metabolic assays (fatty acid oxidation)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP confirming direct NBRE binding plus coactivator recruitment and metabolic readout","pmids":["21757690"],"is_preprint":false},{"year":2008,"finding":"Nurr1 transcriptionally regulates alpha-synuclein expression; decreased Nurr1 expression increases alpha-synuclein transcription, establishing Nurr1 as a transcriptional repressor of alpha-synuclein.","method":"Nurr1 overexpression and knockdown with mRNA level measurement, transcriptional assays","journal":"Neuroreport","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, expression-based readout without ChIP or promoter mutagenesis","pmids":["18463503"],"is_preprint":false},{"year":2005,"finding":"Multiple splice variants of Nurr1 (nurr1a, nurr1b, nurr1c, TINUR, nurr2, nurr2c) are produced by alternative RNA splicing in dopamine neurons; variants nurr1a, nurr1b, nurr1c, and TINUR have significantly reduced transcriptional activity compared with full-length Nurr1, while nurr2 and nurr2c act as dominant negatives.","method":"RT-PCR, sequencing, transfection-based transcriptional reporter assays in dopaminergic SK-N-AS cells","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple isoforms characterized by sequencing and functional reporter assays; single lab","pmids":["16313515"],"is_preprint":false},{"year":2016,"finding":"Nurr1 directly inhibits p21 (Waf1/Cip1) gene transcription by binding to the p21 promoter in a p53-independent manner, thereby promoting G1-S progression and intestinal epithelial cell proliferation after ischemia/reperfusion injury.","method":"ChIP, luciferase reporter assays with deletion/mutation analysis, siRNA knockdown, overexpression, cell cycle analysis","journal":"Journal of molecular medicine","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP confirming direct binding, promoter mutagenesis, and gain/loss-of-function with cell cycle readout","pmids":["27553040"],"is_preprint":false},{"year":2009,"finding":"Nr4a2 is downstream of Brn3a in the developing habenula and mediates expression of a subset of Brn3a-regulated transcripts; Nr4a2 is expressed in a subset of habenular neurons and is required for their proper differentiation as shown by microarray analysis in Brn3a null embryos.","method":"Microarray analysis of Brn3a null embryos, in situ hybridization, genetic epistasis analysis","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis via knockout combined with genome-wide expression profiling; single lab","pmids":["19906978"],"is_preprint":false},{"year":2009,"finding":"Nr4a2 is necessary and sufficient for specification of GABAergic amacrine cell subtype identity in the retina; its targeted inactivation eliminates dopaminergic and p57Kip2+ amacrine cells with a concomitant increase in calbindin+ amacrine cells, and misexpressed Nr4a2 promotes GABAergic AC differentiation.","method":"Conditional knockout mice, retroviral misexpression, dominant-negative construct, immunostaining","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function and gain-of-function with defined cellular phenotypes demonstrating necessity and sufficiency","pmids":["19692620"],"is_preprint":false},{"year":2000,"finding":"Three missense mutations in exon 3 of NURR1 identified in schizophrenic and manic-depressive patients each cause a ~30-40% reduction in in vitro transcriptional activity of NURR1 dimers.","method":"Direct sequencing, in vitro transcriptional activity assays with mutant constructs","journal":"American journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 — functional reporter assays demonstrating transcriptional deficit; single lab","pmids":["11121187"],"is_preprint":false},{"year":2022,"finding":"The lncRNA LUCAT1 controls splicing and stability of NR4A2 mRNA by interacting with heterogeneous nuclear ribonucleoproteins (hnRNP C, M, A2B1); cells lacking LUCAT1 show altered NR4A2 splicing, reduced and delayed NR4A2 expression, and elevated inflammatory gene expression.","method":"CHIRP-MS (comprehensive identification of RNA-binding proteins by mass spectrometry), RNA immunoprecipitation, RNA-seq, LPS stimulation with LUCAT1 KO","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1-2 — proteomic identification of binding partners plus RNA-seq and functional gene expression readout; multiple orthogonal methods","pmids":["36577072"],"is_preprint":false},{"year":2022,"finding":"Nurr1 binds directly to consensus binding sites in the U3 region of the HIV LTR and recruits the CoREST/HDAC1/G9a/EZH2 repressor complex, suppressing HIV transcription in microglial cells; mutation of the Nurr1 DNA-binding domain blocks HIV suppression.","method":"ChIP, Nurr1 overexpression and knockdown, DNA-binding domain mutagenesis, transcriptomics in human microglial cells and iPSC-derived microglia","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrating direct LTR binding, mutagenesis of DBD, CoREST complex recruitment confirmed in multiple microglial cell types","pmids":["35797416"],"is_preprint":false},{"year":2015,"finding":"Nurr1 and Foxa2 physically interact and synergistically protect midbrain dopaminergic neurons against toxic insults both cell-autonomously (in mDA neurons) and in a paracrine mode (via forced expression in neighboring glia); combined AAV-mediated delivery of both factors markedly protected mDA neurons for at least 1 year in a PD mouse model.","method":"Co-immunoprecipitation, AAV-mediated gene delivery in PD mouse model, primary cell culture protection assays","journal":"EMBO molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP demonstrating interaction plus in vivo gene therapy validation; single lab","pmids":["25759364"],"is_preprint":false},{"year":2020,"finding":"Nurr1 directly binds to the RasGRP1 intron and regulates RasGRP1 expression; RasGRP1 in turn regulates the Ras-Raf-MEK-ERK signaling cascade in LPS-induced inflammation in microglia, providing a novel mechanism of Nurr1's anti-inflammatory function.","method":"ChIP-seq in LPS-stimulated BV2 cells, ChIP validation, siRNA knockdown, ERK pathway analysis","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide ChIP-seq with targeted validation identifying direct binding site plus downstream pathway dissection","pmids":["32612143"],"is_preprint":false},{"year":2013,"finding":"Nurr1 expression is regulated by neural activity through voltage-dependent calcium channels (VDCCs) and calcineurin in hippocampal and cortical neurons; calcineurin but not CaMK is critical for activity-dependent Nurr1 induction.","method":"Pharmacological inhibitors of VDCCs and calcineurin/CaMK, KCl/bicuculline/tetrodotoxin manipulations, Western blot/mRNA measurement","journal":"Neuroscience letters","confidence":"Medium","confidence_rationale":"Tier 2-3 — pharmacological dissection of upstream regulatory pathway; single lab, no genetic validation","pmids":["24291696"],"is_preprint":false},{"year":2021,"finding":"Amodiaquine, chloroquine, and cytosporone B bind directly to the Nurr1 LBD as confirmed by protein NMR structural footprinting; many other reported NR4A-active ligands do not bind Nurr1 LBD and show Nurr1-independent transcriptional effects.","method":"Protein NMR structural footprinting, transcriptional reporter assays with Nurr1-dependent and Nurr1-independent readouts","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structural footprinting directly confirming ligand-LBD interaction, distinguishing binders from non-binders","pmids":["33289551"],"is_preprint":false},{"year":2021,"finding":"Nurr1 agonists (chloroquinolineamine analogs) activate Nurr1 transcriptional activity as monomer, homodimer, and heterodimer, and induce robust recruitment of NCoR1 and NCoR2 co-regulators to the Nurr1 LBD while promoting Nurr1 dimerization.","method":"TR-FRET co-regulator recruitment assays, dimerization assays, cellular reporter assays with response elements, gene expression in human astrocytes","journal":"Journal of medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical co-regulator recruitment and dimerization assays; single lab study","pmids":["33629841"],"is_preprint":false},{"year":2019,"finding":"Chloroquine activates Nurr1 function by two distinct mechanisms: direct binding to Nurr1's LBD to promote transcriptional activity, and upregulation of Nurr1 expression through the CREB signaling pathway; CQ activates TREG differentiation and Foxp3 expression in a Nurr1-dependent manner.","method":"Ligand-binding assays (LBD), reporter assays, siRNA and conditional knockout, in vivo IBD model","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — binding assay plus Nurr1-dependent functional rescue; single lab","pmids":["31664129"],"is_preprint":false},{"year":2016,"finding":"NR4A2 (Nurr1) NF-κB transrepression in astrocytes involves nuclear-specific inhibition of p65 binding at inflammatory gene promoters without preventing p65 nuclear translocation; combined RNAi knockdown of Nur77 and Nurr1 abolishes the anti-inflammatory effect of C-DIM5.","method":"ChIP-seq, quantitative PCR arrays, nuclear/cytoplasmic fractionation, siRNA combined knockdown, MPTP mouse astrocyte model","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq revealing nuclear mechanism, genetic epistasis via combined knockdown, multiple orthogonal methods","pmids":["30111648"],"is_preprint":false},{"year":2021,"finding":"NR4A2 suppresses CCR5 gene transcription by binding directly to its promoter in macrophages, and NR4A2 overexpression induces M2 macrophage polarization, protecting cardiomyocytes from high glucose-induced damage; this protective effect is blocked by CCR5 re-expression.","method":"Bioinformatic prediction, luciferase reporter assays, NR4A2 overexpression in vivo and in vitro, co-culture, flow cytometry","journal":"Microvascular research","confidence":"Medium","confidence_rationale":"Tier 2-3 — reporter assay for direct binding, epistatic rescue experiment; single lab, no ChIP","pmids":["34774582"],"is_preprint":false},{"year":2020,"finding":"α-Synuclein overexpression (WT or A53T) reduces Nurr1 transcription by modulating the NF-κB binding site region (-605 to -418 bp) of the Nurr1 promoter; α-SYN downregulates NF-κB expression and decreases NF-κB binding to the Nurr1 promoter without affecting mRNA stability.","method":"Reporter assays with promoter deletion constructs, ChIP for NF-κB at Nurr1 promoter, mRNA stability assays, overexpression in cell lines","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and promoter deletion analysis identifying the regulatory mechanism; single lab","pmids":["32477062"],"is_preprint":false},{"year":2021,"finding":"miR-409-3p directly targets Nr4a2 (validated by luciferase reporter assay); reduced Nr4a2 activates the NF-κB pathway, promoting microglial migration and activation; exosomal miR-409-3p from activated mast cells is transferred to microglia to mediate this effect.","method":"Luciferase 3'UTR reporter assay, Western blot for Nr4a2 and NF-κB, Transwell migration assays, fluorescent exosome transfer","journal":"Journal of neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2-3 — luciferase validation of miRNA target plus functional downstream NF-κB pathway analysis; single lab","pmids":["33750404"],"is_preprint":false},{"year":2016,"finding":"NR4A2 is part of a p53-miR-34 regulatory network: p53 activates endogenous miR-34 which suppresses NR4A2 through a validated miR-34 recognition element in the NR4A2 3'UTR; conversely, NR4A2 overexpression blocks p53 target gene induction including miR-34a, creating a feedback loop.","method":"3'UTR reporter screen, miRNA recognition element mapping and mutagenesis, miR-34 overexpression, p53 pathway activation, cell proliferation assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — validated 3'UTR element by mutagenesis, bidirectional feedback demonstrated; single lab","pmids":["27121375"],"is_preprint":false},{"year":2020,"finding":"NR4A2 directly transactivates CDK4 gene expression by binding to the CDK4 promoter region, facilitating gastric cancer cell proliferation; H. pylori induces NR4A2 via the PI3K/AKT-Sp1 pathway, and Sp1 binds the Nurr1 promoter to activate its transcription.","method":"ChIP, luciferase reporter assays, siRNA knockdown and overexpression, in vivo xenograft","journal":"EBioMedicine","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP demonstrating direct CDK4 promoter binding plus in vivo validation; single lab","pmids":["32114387"],"is_preprint":false},{"year":2021,"finding":"NR4A2 promotes cytoprotective autophagy in pancreatic cancer cells via transcriptional regulation of ATG7 and ATG12; gemcitabine induces NR4A2 expression and the NR4A2-ATG7/ATG12 axis is required for gemcitabine-induced drug resistance.","method":"RNA-seq with CRISPR/Cas9 KO, KEGG pathway analysis, NR4A2 knockdown/overexpression, drug resistance assays","journal":"Cancer research communications","confidence":"Medium","confidence_rationale":"Tier 2 — RNA-seq with CRISPR KO identifying ATG7/ATG12 as direct targets; single lab, no ChIP validation","pmids":["35582016"],"is_preprint":false},{"year":2019,"finding":"NR4A2 transcriptional activity represses the TSP-1 promoter in synoviocytes independent of DNA binding; ectopic NR4A2 expression reduces TSP-1 mRNA/protein with concomitant increases in VEGF and IL-8; depletion of NR4A2 shifts the TSP-1/VEGF expression ratio.","method":"Promoter-luciferase assays with deletion analysis, stable NR4A2 overexpression and shRNA knockdown, ELISA, qRT-PCR","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2-3 — promoter deletion analysis and reciprocal gain/loss of function; single lab, mechanism of DNA-binding independence established by reporter assays","pmids":["23933487"],"is_preprint":false},{"year":2019,"finding":"FoxM1 directly promotes Nurr1 transcription by binding to the Nurr1 promoter; FoxM1 inhibition downregulates Nurr1 expression and Ki-67, and FoxM1 overexpression promotes intestinal epithelial cell proliferation after hypoxia/reperfusion via Nurr1 activation.","method":"ChIP, luciferase reporter assays, siRNA knockdown, forced expression, in vivo I/R rat model","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP confirming direct FoxM1 binding to Nurr1 promoter plus in vivo model; single lab","pmids":["31704909"],"is_preprint":false}],"current_model":"NR4A2/Nurr1 is a ligand-regulated orphan nuclear receptor transcription factor that binds DNA as a monomer (at NBRE elements), homodimer, or RXR heterodimer to transactivate dopaminergic neuron target genes (TH, DAT, VMAT2, AADC, RET, Pitx3, CDK4, VIP, osteocalcin) and repress inflammatory genes (via docking to NF-κB p65 and recruiting the CoREST/HDAC1/G9a/EZH2 repressor complex); its LBD contains a dynamic non-canonical ligand-binding pocket where endogenous prostaglandins (PGE1/PGA1) and dopamine metabolite DHI form covalent adducts with Cys566 to activate transcription, while synthetic chloroquine-scaffold compounds and NSAIDs modulate its activity bidirectionally through LBD binding and distinct co-regulator (NCoR1/2) recruitment patterns, and its expression is itself regulated by neural activity (via VDCC-calcineurin), NF-κB, CREB, FoxM1, miR-34, and miR-409-3p."},"narrative":{"teleology":[{"year":2000,"claim":"Establishing that NR4A2 coding variants found in psychiatric patients reduce transcriptional activity provided the first evidence that diminished Nurr1 function has pathological consequences beyond dopamine neuron specification.","evidence":"Direct sequencing of schizophrenia/manic-depression patients with in vitro reporter assays of mutant constructs","pmids":["11121187"],"confidence":"Medium","gaps":["Single cohort; causality not established by family segregation or rescue","No structural basis for how exon 3 mutations reduce dimer activity"]},{"year":2003,"claim":"Demonstrating that Nurr1 directly induces AADC and VMAT2 in dopaminergic cells—and that these genes are deregulated in Nurr1 knockout embryos—established Nurr1 as an instructive transcription factor for the full dopamine biosynthesis and storage program, not just TH alone.","evidence":"Inducible Nurr1 cell line with DA content measurement; in situ hybridization in Nurr1 KO embryos","pmids":["12915123"],"confidence":"High","gaps":["Genome-wide target repertoire not yet defined","Whether Nurr1 binds AADC/VMAT2 promoters directly was not shown by ChIP at this stage"]},{"year":2004,"claim":"Identifying that Nurr1 monomers bind an NBRE-like element in the osteocalcin promoter demonstrated that Nurr1 functions as a direct transcriptional activator outside the nervous system.","evidence":"EMSA, ChIP, and mutagenesis in primary osteoblasts","pmids":["15485875"],"confidence":"High","gaps":["Physiological relevance of Nurr1 in bone homeostasis not fully delineated"]},{"year":2006,"claim":"Crystallographic analysis revealing a collapsed canonical ligand pocket with an alternative hydrophobic co-activator surface on the LBD explained how Nurr1 could be constitutively active yet still regulatable, resolving its classification as an 'orphan' receptor.","evidence":"Crystal structure analysis, site-directed mutagenesis, proteasome inhibitor experiments","pmids":["17032747"],"confidence":"High","gaps":["Whether endogenous ligands exist was unresolved","Identity of co-activators recruited to the alternative surface unknown"]},{"year":2008,"claim":"Showing that NR4A2 augments IL-17 and IFN-γ promoter activity in pathogenic T cells and is required for encephalitogenic T cell function revealed a pro-inflammatory role for Nurr1 in adaptive immunity, distinct from its neurotrophic identity.","evidence":"Reporter assays plus EAE adoptive transfer model","pmids":["18550828"],"confidence":"High","gaps":["Direct promoter binding not confirmed by ChIP","Mechanism distinguishing activating vs. repressive NR4A2 function in T cells vs. myeloid cells unclear"]},{"year":2009,"claim":"The discovery that Nurr1 docks onto NF-κB p65 at inflammatory gene promoters and recruits the CoREST corepressor complex to clear p65 provided the molecular mechanism for signal-dependent transrepression, explaining how Nurr1 protects dopaminergic neurons from neuroinflammation.","evidence":"ChIP, Co-IP, reporter assays, siRNA, conditional knockout mice in microglia/astrocytes","pmids":["19345186"],"confidence":"High","gaps":["Whether the CoREST-dependent mechanism operates in non-CNS inflammatory contexts was unknown","Post-translational modifications governing p65-docking were not identified"]},{"year":2009,"claim":"Genetic loss- and gain-of-function studies showing Nr4a2 is necessary and sufficient for GABAergic amacrine cell specification in the retina expanded its role beyond midbrain DA neurons to a general neuronal subtype selector.","evidence":"Conditional knockout and retroviral misexpression in mouse retina","pmids":["19692620"],"confidence":"High","gaps":["Direct transcriptional targets in amacrine cells not identified","Whether Nr4a2 coordinates with the same co-regulators as in DA neurons unknown"]},{"year":2011,"claim":"Demonstrating that Nr4a2 directly binds the Foxp3 locus and mediates permissive histone modifications established it as a key inducer of regulatory T cell differentiation, bridging its immune roles from purely pro-inflammatory (Th17) to immunosuppressive (Treg).","evidence":"ChIP, conditional T cell–specific KO, in vitro suppression assays, colitis model","pmids":["21468021"],"confidence":"High","gaps":["How the same factor drives both Th17 and Treg programs in different contexts was unresolved","Signals specifying the switch not identified"]},{"year":2011,"claim":"ChIP-based identification that PGE2-induced NR4A2 binds NBREs in fatty acid oxidation gene regulatory regions linked NR4A2 to metabolic reprogramming in colorectal cancer cells.","evidence":"ChIP, NBRE reporter assays, siRNA knockdown, metabolic assays","pmids":["21757690"],"confidence":"High","gaps":["Whether NR4A2 regulation of FAO is a general metabolic function or cancer-specific unknown"]},{"year":2013,"claim":"Placing NR4A2 upstream of the IL-21 autocrine loop in Th17 differentiation—with rescue by exogenous IL-21—resolved the epistatic position of NR4A2 in the Th17 program.","evidence":"siRNA knockdown, cytokine rescue, in vivo EAE siRNA treatment","pmids":["23437182"],"confidence":"High","gaps":["Whether NR4A2 directly binds IL-21 regulatory regions not confirmed by ChIP"]},{"year":2018,"claim":"NMR and HDX-MS revealed that the Nurr1 LBD pocket, though collapsed in crystals, is dynamically accessible on microsecond-to-millisecond timescales and can accommodate unsaturated fatty acids, overturning the view that the pocket is permanently occluded.","evidence":"Solution NMR, HDX-MS, molecular dynamics simulations","pmids":["30416039"],"confidence":"High","gaps":["Identity of endogenous high-affinity ligands still unknown at this point"]},{"year":2019,"claim":"Crystal structures of DHI covalently bound to Cys566 in the Nurr1 LBD identified the first endogenous ligand for Nurr1—a dopamine metabolite—establishing a feedback mechanism linking dopamine catabolism to transcriptional maintenance of DA neuron identity.","evidence":"X-ray crystallography, biophysical binding assays, reporter assays, zebrafish model","pmids":["30853418"],"confidence":"High","gaps":["Physiological concentrations of DHI in the brain and whether they reach activating levels not determined","Whether DHI activates Nurr1 in non-dopaminergic cells unknown"]},{"year":2019,"claim":"Crystal structures of the NR4A2 DBD dimer on NurRE DNA at 2.6–2.8 Å resolution defined the structural basis for homodimerization on inverted repeat elements, explaining how Nurr1 achieves diverse DNA-binding modes (monomer vs. dimer).","evidence":"X-ray crystallography with mutagenesis (V298K) and biochemical DNA-binding assays","pmids":["31723028"],"confidence":"High","gaps":["Full-length structure including LBD-DBD communication not resolved","Heterodimer structure with RXR not determined"]},{"year":2020,"claim":"The crystal structure of PGA1 covalently adducted to Cys566 with a 21° shift of helix H12 provided the first high-resolution activation mechanism for Nurr1, showing that prostaglandin metabolites are bona fide endogenous agonists.","evidence":"2.05 Å X-ray crystallography, mutagenesis, cell-based and in vivo MPTP model validation","pmids":["32451509"],"confidence":"High","gaps":["Whether PGA1 or PGE1 reaches sufficient concentrations in the brain niche","Structural basis for inverse agonism or antagonism not established"]},{"year":2021,"claim":"NMR structural footprinting discriminating true LBD-binding ligands (amodiaquine, chloroquine) from non-binders among reported NR4A modulators clarified the pharmacological landscape and showed that many published 'Nurr1 agonists' act through Nurr1-independent mechanisms.","evidence":"Protein NMR footprinting, Nurr1-dependent and -independent reporter assays","pmids":["33289551"],"confidence":"High","gaps":["Binding mode and co-crystal structure of chloroquine-class compounds not yet determined","In vivo selectivity profiles of validated LBD binders incomplete"]},{"year":2022,"claim":"Demonstrating that Nurr1 directly binds the HIV LTR and recruits the CoREST/HDAC1/G9a/EZH2 complex to silence HIV transcription in microglia extended the CoREST-dependent transrepression paradigm from inflammatory genes to viral latency maintenance.","evidence":"ChIP, DBD mutagenesis, transcriptomics in human microglial cells and iPSC-derived microglia","pmids":["35797416"],"confidence":"High","gaps":["Whether Nurr1-mediated HIV silencing operates in other CNS reservoir cells (astrocytes, perivascular macrophages) unknown","Contribution relative to other latency-maintaining factors not quantified"]},{"year":2022,"claim":"Identification of the lncRNA LUCAT1 as a post-transcriptional regulator that controls NR4A2 mRNA splicing and stability via hnRNPs revealed a new layer of NR4A2 regulation that links lncRNA biology to inflammatory gene control.","evidence":"CHIRP-MS, RNA immunoprecipitation, RNA-seq in LUCAT1 KO cells","pmids":["36577072"],"confidence":"High","gaps":["Whether LUCAT1-dependent splicing produces functionally distinct NR4A2 isoforms with altered activity","In vivo relevance of LUCAT1-NR4A2 axis in inflammation not tested"]},{"year":null,"claim":"Key unresolved questions include: the structural basis for how NR4A2 switches between transcriptional activation and CoREST-dependent transrepression in different cellular contexts; the full-length structure encompassing LBD-DBD allosteric communication; and the physiological ligand concentrations of DHI and prostaglandins in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length NR4A2 structure available","Context-dependent switch between activation and repression mechanistically unresolved","In vivo ligand occupancy not measured"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,6,7,9,10,11,14,15,16,17,20,25,37]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,10,11,15,17,25,27]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,13,32]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,5,10,25,32]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,6,7,8,14,32,33,35]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[13,27,34,36]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[9,21,22]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[9,12,28]}],"complexes":["CoREST/HDAC1/G9a/EZH2 corepressor complex"],"partners":["NFKB1 (P65/RELA)","FOXA2","TP53","NCOR1","NCOR2","RCOR1"],"other_free_text":[]},"mechanistic_narrative":"NR4A2 (Nurr1) is an orphan nuclear receptor transcription factor that functions as a master regulator of midbrain dopaminergic neuron identity and a signal-dependent modulator of inflammatory gene expression across multiple immune and neural cell types. It binds DNA as a monomer at NBRE elements or as a homodimer on NurRE inverted repeats to directly transactivate dopaminergic genes (TH, AADC, VMAT2, RET, Pitx3), cell-cycle regulators (CDK4, p21), and metabolic targets (osteocalcin, FAO genes, arginase 1, FGF23), while also repressing inflammatory gene transcription by docking to NF-κB p65 on target promoters and recruiting the CoREST/HDAC1/G9a/EZH2 corepressor complex [PMID:19345186, PMID:12915123, PMID:31723028, PMID:25953901]. Although originally classified as a ligand-independent receptor due to a collapsed canonical ligand-binding pocket, its LBD is conformationally dynamic and accommodates endogenous ligands—prostaglandin A1 and the dopamine metabolite 5,6-dihydroxyindole—that form covalent adducts with Cys566, inducing activation-function helix repositioning and transcriptional activation [PMID:32451509, PMID:30853418, PMID:30416039]. Beyond the nervous system, NR4A2 drives Foxp3 expression and regulatory T cell differentiation, promotes Th17 polarization via an IL-21 autocrine loop, and directs M2 macrophage polarization through arginase 1 induction, placing it at the interface of adaptive and innate immunity [PMID:21468021, PMID:23437182, PMID:25953901]."},"prefetch_data":{"uniprot":{"accession":"P43354","full_name":"Nuclear receptor subfamily 4 group A member 2","aliases":["Immediate-early response protein NOT","Orphan nuclear receptor NURR1","Transcriptionally-inducible nuclear receptor"],"length_aa":598,"mass_kda":66.6,"function":"Transcriptional regulator which is important for the differentiation and maintenance of meso-diencephalic dopaminergic (mdDA) neurons during development (PubMed:15716272, PubMed:17184956). It is crucial for expression of a set of genes such as SLC6A3, SLC18A2, TH and DRD2 which are essential for development of mdDA neurons (By similarity)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P43354/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NR4A2","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NR4A2","total_profiled":1310},"omim":[{"mim_id":"619911","title":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM; IDLDP","url":"https://www.omim.org/entry/619911"},{"mim_id":"613677","title":"HYPERALDOSTERONISM, FAMILIAL, TYPE III; HALD3","url":"https://www.omim.org/entry/613677"},{"mim_id":"612237","title":"CHONDROSARCOMA, EXTRASKELETAL MYXOID","url":"https://www.omim.org/entry/612237"},{"mim_id":"605635","title":"HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2","url":"https://www.omim.org/entry/605635"},{"mim_id":"601828","title":"NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2","url":"https://www.omim.org/entry/601828"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear speckles","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"adrenal gland","ntpm":125.3},{"tissue":"bone marrow","ntpm":126.4},{"tissue":"ovary","ntpm":122.1}],"url":"https://www.proteinatlas.org/search/NR4A2"},"hgnc":{"alias_symbol":["TINUR","NOT","RNR1","HZF-3"],"prev_symbol":["NURR1"]},"alphafold":{"accession":"P43354","domains":[{"cath_id":"3.30.50.10","chopping":"272-325","consensus_level":"high","plddt":96.1213,"start":272,"end":325},{"cath_id":"1.10.565.10","chopping":"363-594","consensus_level":"high","plddt":91.1801,"start":363,"end":594}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P43354","model_url":"https://alphafold.ebi.ac.uk/files/AF-P43354-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P43354-F1-predicted_aligned_error_v6.png","plddt_mean":66.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NR4A2","jax_strain_url":"https://www.jax.org/strain/search?query=NR4A2"},"sequence":{"accession":"P43354","fasta_url":"https://rest.uniprot.org/uniprotkb/P43354.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P43354/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P43354"}},"corpus_meta":[{"pmid":"19345186","id":"PMC_19345186","title":"A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19345186","citation_count":770,"is_preprint":false},{"pmid":"12496759","id":"PMC_12496759","title":"Mutations in NR4A2 associated with familial Parkinson disease.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12496759","citation_count":377,"is_preprint":false},{"pmid":"16243425","id":"PMC_16243425","title":"The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease.","date":"2005","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/16243425","citation_count":265,"is_preprint":false},{"pmid":"21468021","id":"PMC_21468021","title":"The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells.","date":"2011","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/21468021","citation_count":176,"is_preprint":false},{"pmid":"12915123","id":"PMC_12915123","title":"Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells.","date":"2003","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12915123","citation_count":140,"is_preprint":false},{"pmid":"11121187","id":"PMC_11121187","title":"NURR1 mutations in cases of schizophrenia and manic-depressive disorder.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11121187","citation_count":123,"is_preprint":false},{"pmid":"24940803","id":"PMC_24940803","title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.","date":"2014","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/24940803","citation_count":123,"is_preprint":false},{"pmid":"15340833","id":"PMC_15340833","title":"Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells.","date":"2004","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/15340833","citation_count":122,"is_preprint":false},{"pmid":"19906978","id":"PMC_19906978","title":"Brn3a and Nurr1 mediate a gene regulatory pathway for habenula development.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19906978","citation_count":100,"is_preprint":false},{"pmid":"15891117","id":"PMC_15891117","title":"RNR1, a 3'-5' exoribonuclease belonging to the RNR superfamily, catalyzes 3' maturation of chloroplast ribosomal RNAs in Arabidopsis thaliana.","date":"2005","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15891117","citation_count":99,"is_preprint":false},{"pmid":"27012974","id":"PMC_27012974","title":"Nurr1-Based Therapies for Parkinson's Disease.","date":"2016","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/27012974","citation_count":99,"is_preprint":false},{"pmid":"23161447","id":"PMC_23161447","title":"Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory.","date":"2012","source":"Learning & memory (Cold Spring Harbor, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23161447","citation_count":96,"is_preprint":false},{"pmid":"30684217","id":"PMC_30684217","title":"Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death.","date":"2019","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/30684217","citation_count":91,"is_preprint":false},{"pmid":"30515963","id":"PMC_30515963","title":"Nurr1 (NR4A2) regulates Alzheimer's disease-related pathogenesis and cognitive function in the 5XFAD mouse model.","date":"2018","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/30515963","citation_count":83,"is_preprint":false},{"pmid":"18945812","id":"PMC_18945812","title":"Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1.","date":"2008","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/18945812","citation_count":83,"is_preprint":false},{"pmid":"11074005","id":"PMC_11074005","title":"Mutational and structural analyses of the ribonucleotide reductase inhibitor Sml1 define its Rnr1 interaction domain whose inactivation allows suppression of mec1 and rad53 lethality.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11074005","citation_count":78,"is_preprint":false},{"pmid":"16532445","id":"PMC_16532445","title":"Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.","date":"2006","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/16532445","citation_count":77,"is_preprint":false},{"pmid":"25759364","id":"PMC_25759364","title":"Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.","date":"2015","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25759364","citation_count":76,"is_preprint":false},{"pmid":"25953901","id":"PMC_25953901","title":"Nuclear Receptor Nr4a2 Promotes Alternative Polarization of Macrophages and Confers Protection in Sepsis.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25953901","citation_count":75,"is_preprint":false},{"pmid":"32451509","id":"PMC_32451509","title":"PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function.","date":"2020","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/32451509","citation_count":74,"is_preprint":false},{"pmid":"34032273","id":"PMC_34032273","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.","date":"2021","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/34032273","citation_count":73,"is_preprint":false},{"pmid":"18550828","id":"PMC_18550828","title":"Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18550828","citation_count":72,"is_preprint":false},{"pmid":"23437182","id":"PMC_23437182","title":"Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23437182","citation_count":67,"is_preprint":false},{"pmid":"11159837","id":"PMC_11159837","title":"Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells.","date":"2001","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11159837","citation_count":65,"is_preprint":false},{"pmid":"21573136","id":"PMC_21573136","title":"Ixr1 is required for the expression of the ribonucleotide reductase Rnr1 and maintenance of dNTP pools.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21573136","citation_count":63,"is_preprint":false},{"pmid":"23322982","id":"PMC_23322982","title":"Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers.","date":"2012","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23322982","citation_count":57,"is_preprint":false},{"pmid":"30853418","id":"PMC_30853418","title":"Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite.","date":"2019","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/30853418","citation_count":57,"is_preprint":false},{"pmid":"22405837","id":"PMC_22405837","title":"Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells.","date":"2012","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22405837","citation_count":56,"is_preprint":false},{"pmid":"33289551","id":"PMC_33289551","title":"Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1.","date":"2020","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33289551","citation_count":54,"is_preprint":false},{"pmid":"22143616","id":"PMC_22143616","title":"The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss.","date":"2011","source":"International journal of obesity (2005)","url":"https://pubmed.ncbi.nlm.nih.gov/22143616","citation_count":54,"is_preprint":false},{"pmid":"21480782","id":"PMC_21480782","title":"Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration.","date":"2011","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/21480782","citation_count":53,"is_preprint":false},{"pmid":"36703399","id":"PMC_36703399","title":"The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs.","date":"2020","source":"Communications chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36703399","citation_count":52,"is_preprint":false},{"pmid":"21757690","id":"PMC_21757690","title":"Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21757690","citation_count":46,"is_preprint":false},{"pmid":"30416039","id":"PMC_30416039","title":"Defining a Canonical Ligand-Binding Pocket in the Orphan Nuclear Receptor Nurr1.","date":"2018","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/30416039","citation_count":46,"is_preprint":false},{"pmid":"19671681","id":"PMC_19671681","title":"NGFI-B nuclear orphan receptor Nurr1 interacts with p53 and suppresses its transcriptional activity.","date":"2009","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/19671681","citation_count":44,"is_preprint":false},{"pmid":"15485875","id":"PMC_15485875","title":"Nuclear orphan receptor Nurr1 directly transactivates the osteocalcin gene in osteoblasts.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15485875","citation_count":43,"is_preprint":false},{"pmid":"22363463","id":"PMC_22363463","title":"Direct regulation of Pitx3 expression by Nurr1 in culture and in developing mouse midbrain.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22363463","citation_count":43,"is_preprint":false},{"pmid":"36948326","id":"PMC_36948326","title":"Protective effect of Nr4a2 (Nurr1) against LPS-induced depressive-like behaviors via regulating activity of microglia and CamkII neurons in anterior cingulate cortex.","date":"2023","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/36948326","citation_count":42,"is_preprint":false},{"pmid":"30111648","id":"PMC_30111648","title":"Compensatory Expression of Nur77 and Nurr1 Regulates NF-κB-Dependent Inflammatory Signaling in Astrocytes.","date":"2018","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30111648","citation_count":42,"is_preprint":false},{"pmid":"19345183","id":"PMC_19345183","title":"A Nurr1 pathway for neuroprotection.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19345183","citation_count":42,"is_preprint":false},{"pmid":"33750404","id":"PMC_33750404","title":"Exosomal miR-409-3p secreted from activated mast cells promotes microglial migration, activation and neuroinflammation by targeting Nr4a2 to activate the NF-κB pathway.","date":"2021","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/33750404","citation_count":41,"is_preprint":false},{"pmid":"22275273","id":"PMC_22275273","title":"Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/22275273","citation_count":40,"is_preprint":false},{"pmid":"18463503","id":"PMC_18463503","title":"Nurr1 transcriptionally regulates the expression of alpha-synuclein.","date":"2008","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/18463503","citation_count":40,"is_preprint":false},{"pmid":"29429051","id":"PMC_29429051","title":"Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model.","date":"2018","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/29429051","citation_count":40,"is_preprint":false},{"pmid":"20533997","id":"PMC_20533997","title":"Nurr1 regulates RET expression in dopamine neurons of adult rat midbrain.","date":"2010","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20533997","citation_count":39,"is_preprint":false},{"pmid":"37463889","id":"PMC_37463889","title":"An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease models.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37463889","citation_count":38,"is_preprint":false},{"pmid":"36577072","id":"PMC_36577072","title":"The lncRNA LUCAT1 is elevated in inflammatory disease and restrains inflammation by regulating the splicing and stability of NR4A2.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36577072","citation_count":37,"is_preprint":false},{"pmid":"27333991","id":"PMC_27333991","title":"Expression of mitochondrial genes MT-ND1, MT-ND6, MT-CYB, MT-COI, MT-ATP6, and 12S/MT-RNR1 in colorectal adenopolyps.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27333991","citation_count":36,"is_preprint":false},{"pmid":"35761385","id":"PMC_35761385","title":"The role of NURR1 in metabolic abnormalities of Parkinson's disease.","date":"2022","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/35761385","citation_count":35,"is_preprint":false},{"pmid":"10216261","id":"PMC_10216261","title":"Organization of the human orphan nuclear receptor Nurr1 gene.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10216261","citation_count":35,"is_preprint":false},{"pmid":"19429166","id":"PMC_19429166","title":"Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.","date":"2009","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/19429166","citation_count":35,"is_preprint":false},{"pmid":"31664129","id":"PMC_31664129","title":"Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31664129","citation_count":35,"is_preprint":false},{"pmid":"32477062","id":"PMC_32477062","title":"α-Synuclein Negatively Regulates Nurr1 Expression Through NF-κB-Related Mechanism.","date":"2020","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32477062","citation_count":34,"is_preprint":false},{"pmid":"26862735","id":"PMC_26862735","title":"Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26862735","citation_count":34,"is_preprint":false},{"pmid":"19692620","id":"PMC_19692620","title":"Subtype specification of GABAergic amacrine cells by the orphan nuclear receptor Nr4a2/Nurr1.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19692620","citation_count":33,"is_preprint":false},{"pmid":"29770430","id":"PMC_29770430","title":"NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder.","date":"2018","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29770430","citation_count":33,"is_preprint":false},{"pmid":"27121375","id":"PMC_27121375","title":"The orphan nuclear receptor NR4A2 is part of a p53-microRNA-34 network.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27121375","citation_count":32,"is_preprint":false},{"pmid":"37127285","id":"PMC_37127285","title":"Development of a Potent Nurr1 Agonist Tool for In Vivo Applications.","date":"2023","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37127285","citation_count":32,"is_preprint":false},{"pmid":"32612143","id":"PMC_32612143","title":"Nurr1 performs its anti-inflammatory function by regulating RasGRP1 expression in neuro-inflammation.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32612143","citation_count":31,"is_preprint":false},{"pmid":"26343273","id":"PMC_26343273","title":"Age-and gender-related pattern of methylation in the MT-RNR1 gene.","date":"2015","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/26343273","citation_count":30,"is_preprint":false},{"pmid":"35797147","id":"PMC_35797147","title":"Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration.","date":"2022","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35797147","citation_count":29,"is_preprint":false},{"pmid":"34880728","id":"PMC_34880728","title":"Nr4a2 Transcription Factor in Hippocampal Synaptic Plasticity, Memory and Cognitive Dysfunction: A Perspective Review.","date":"2021","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34880728","citation_count":29,"is_preprint":false},{"pmid":"22748824","id":"PMC_22748824","title":"The function and mechanisms of Nurr1 action in midbrain dopaminergic neurons, from development and maintenance to survival.","date":"2012","source":"International review of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22748824","citation_count":29,"is_preprint":false},{"pmid":"23933487","id":"PMC_23933487","title":"Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity.","date":"2013","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23933487","citation_count":29,"is_preprint":false},{"pmid":"31754919","id":"PMC_31754919","title":"Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.","date":"2019","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31754919","citation_count":28,"is_preprint":false},{"pmid":"15635701","id":"PMC_15635701","title":"Identification and characterization of human NR4A2 polymorphisms in attention deficit hyperactivity disorder.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15635701","citation_count":28,"is_preprint":false},{"pmid":"27553040","id":"PMC_27553040","title":"Nurr1 promotes intestinal regeneration after ischemia/reperfusion injury by inhibiting the expression of p21 (Waf1/Cip1).","date":"2016","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/27553040","citation_count":28,"is_preprint":false},{"pmid":"17032747","id":"PMC_17032747","title":"Characterization of the Nurr1 ligand-binding domain co-activator interaction surface.","date":"2006","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17032747","citation_count":28,"is_preprint":false},{"pmid":"18409190","id":"PMC_18409190","title":"Altered expression of 12S/MT-RNR1, MT-CO2/COX2, and MT-ATP6 mitochondrial genes in prostate cancer.","date":"2008","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/18409190","citation_count":27,"is_preprint":false},{"pmid":"35132190","id":"PMC_35132190","title":"CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK/AKT-Nurr1 signal pathways.","date":"2022","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/35132190","citation_count":27,"is_preprint":false},{"pmid":"32366965","id":"PMC_32366965","title":"De novo variants of NR4A2 are associated with neurodevelopmental disorder and epilepsy.","date":"2020","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32366965","citation_count":26,"is_preprint":false},{"pmid":"37384814","id":"PMC_37384814","title":"Sodium Butyrate Ameliorates Deoxynivalenol-Induced Oxidative Stress and Inflammation in the Porcine Liver via NR4A2-Mediated Histone Acetylation.","date":"2023","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37384814","citation_count":26,"is_preprint":false},{"pmid":"33010383","id":"PMC_33010383","title":"HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/33010383","citation_count":25,"is_preprint":false},{"pmid":"16313515","id":"PMC_16313515","title":"Dopamine neurons express multiple isoforms of the nuclear receptor nurr1 with diminished transcriptional activity.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16313515","citation_count":25,"is_preprint":false},{"pmid":"26678495","id":"PMC_26678495","title":"Role of Nurr1 in the Generation and Differentiation of Dopaminergic Neurons from Stem Cells.","date":"2015","source":"Neurotoxicity research","url":"https://pubmed.ncbi.nlm.nih.gov/26678495","citation_count":25,"is_preprint":false},{"pmid":"36555826","id":"PMC_36555826","title":"Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36555826","citation_count":24,"is_preprint":false},{"pmid":"33629841","id":"PMC_33629841","title":"Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33629841","citation_count":24,"is_preprint":false},{"pmid":"31723028","id":"PMC_31723028","title":"Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31723028","citation_count":24,"is_preprint":false},{"pmid":"38570607","id":"PMC_38570607","title":"Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/38570607","citation_count":23,"is_preprint":false},{"pmid":"33479411","id":"PMC_33479411","title":"Potent synthetic and endogenous ligands for the adopted orphan nuclear receptor Nurr1.","date":"2021","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33479411","citation_count":23,"is_preprint":false},{"pmid":"31574937","id":"PMC_31574937","title":"NURR1 Impairment in Multiple Sclerosis.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31574937","citation_count":23,"is_preprint":false},{"pmid":"25717285","id":"PMC_25717285","title":"Orphan nuclear receptor NR4A2 induces transcription of the immunomodulatory peptide hormone prolactin.","date":"2015","source":"Journal of inflammation (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25717285","citation_count":22,"is_preprint":false},{"pmid":"35797416","id":"PMC_35797416","title":"Recruitment of the CoREST transcription repressor complexes by Nerve Growth factor IB-like receptor (Nurr1/NR4A2) mediates silencing of HIV in microglial cells.","date":"2022","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/35797416","citation_count":21,"is_preprint":false},{"pmid":"31811028","id":"PMC_31811028","title":"NURR1 and ERR1 Modulate the Expression of Genes of a DRD2 Coexpression Network Enriched for Schizophrenia Risk.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31811028","citation_count":21,"is_preprint":false},{"pmid":"23741394","id":"PMC_23741394","title":"Sen1p contributes to genomic integrity by regulating expression of ribonucleotide reductase 1 (RNR1) in Saccharomyces cerevisiae.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23741394","citation_count":21,"is_preprint":false},{"pmid":"24291696","id":"PMC_24291696","title":"Nurr1 expression is regulated by voltage-dependent calcium channels and calcineurin in cultured hippocampal neurons.","date":"2013","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/24291696","citation_count":20,"is_preprint":false},{"pmid":"31087449","id":"PMC_31087449","title":"Transplantation of Nurr1-overexpressing neural stem cells and microglia for treating parkinsonian rats.","date":"2019","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/31087449","citation_count":20,"is_preprint":false},{"pmid":"28423575","id":"PMC_28423575","title":"Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28423575","citation_count":19,"is_preprint":false},{"pmid":"34248958","id":"PMC_34248958","title":"Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors NR4A2 and NR4A3 Reveals Distinct Signalling Roles Related to Antigen Presentation and Viral Response.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34248958","citation_count":19,"is_preprint":false},{"pmid":"30797853","id":"PMC_30797853","title":"Hydroxychloroquine antiparkinsonian potential: Nurr1 modulation versus autophagy inhibition.","date":"2019","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/30797853","citation_count":19,"is_preprint":false},{"pmid":"33742120","id":"PMC_33742120","title":"Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/33742120","citation_count":19,"is_preprint":false},{"pmid":"31704909","id":"PMC_31704909","title":"The transcription factor FoxM1 activates Nurr1 to promote intestinal regeneration after ischemia/reperfusion injury.","date":"2019","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31704909","citation_count":19,"is_preprint":false},{"pmid":"30998946","id":"PMC_30998946","title":"Epigenetic regulation of immediate-early gene Nr4a2/Nurr1 in the medial habenula during reinstatement of cocaine-associated behavior.","date":"2019","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30998946","citation_count":18,"is_preprint":false},{"pmid":"32645618","id":"PMC_32645618","title":"The mutation frequencies of GJB2, GJB3, SLC26A4 and MT-RNR1 of patients with severe to profound sensorineural hearing loss in northwest China.","date":"2020","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/32645618","citation_count":18,"is_preprint":false},{"pmid":"34165961","id":"PMC_34165961","title":"Analogs of the Dopamine Metabolite 5,6-Dihydroxyindole Bind Directly to and Activate the Nuclear Receptor Nurr1.","date":"2021","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/34165961","citation_count":18,"is_preprint":false},{"pmid":"33716718","id":"PMC_33716718","title":"Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson's Disease. A Systematic Review.","date":"2021","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33716718","citation_count":18,"is_preprint":false},{"pmid":"32114387","id":"PMC_32114387","title":"Orphan nuclear receptor Nurr1 promotes Helicobacter pylori-associated gastric carcinogenesis by directly enhancing CDK4 expression.","date":"2020","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/32114387","citation_count":17,"is_preprint":false},{"pmid":"35582016","id":"PMC_35582016","title":"Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma.","date":"2021","source":"Cancer research communications","url":"https://pubmed.ncbi.nlm.nih.gov/35582016","citation_count":17,"is_preprint":false},{"pmid":"34774582","id":"PMC_34774582","title":"NR4A2 alleviates cardiomyocyte loss and myocardial injury in rats by transcriptionally suppressing CCR5 and inducing M2 polarization of macrophages.","date":"2021","source":"Microvascular research","url":"https://pubmed.ncbi.nlm.nih.gov/34774582","citation_count":16,"is_preprint":false},{"pmid":"20407282","id":"PMC_20407282","title":"Cytokines induce NF-κB, Nurr1 and corticotropin-releasing factor gene transcription in hypothalamic 4B cells.","date":"2010","source":"Neuroimmunomodulation","url":"https://pubmed.ncbi.nlm.nih.gov/20407282","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48936,"output_tokens":9230,"usd":0.142629},"stage2":{"model":"claude-opus-4-6","input_tokens":13159,"output_tokens":4094,"usd":0.252217},"total_usd":0.394846,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"Nurr1 inhibits pro-inflammatory gene expression in microglia and astrocytes by docking to NF-κB-p65 on target inflammatory gene promoters in a signal-dependent manner, then recruiting the CoREST corepressor complex, resulting in clearance of NF-κB-p65 and transcriptional repression, thereby protecting dopaminergic neurons from inflammation-induced death.\",\n      \"method\": \"ChIP, co-immunoprecipitation, reporter assays, siRNA knockdown, primary cell culture, conditional knockout mice\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (ChIP, Co-IP, reporter assays, genetic KO) with clear mechanistic dissection in a highly-cited study\",\n      \"pmids\": [\"19345186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Prostaglandin E1 (PGE1) and its metabolite PGA1 directly bind the ligand-binding domain (LBD) of Nurr1; PGA1 forms a covalent Michael adduct with Cys566 and induces a 21° conformational shift of the activation function-2 helix (H12), activating Nurr1 transcriptional function in a Nurr1-dependent manner.\",\n      \"method\": \"X-ray crystallography (2.05 Å), biophysical binding assays, mutagenesis, cell-based reporter assays, in vivo MPTP mouse model\",\n      \"journal\": \"Nature chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with covalent adduct confirmed, mutagenesis, and functional validation in cells and in vivo\",\n      \"pmids\": [\"32451509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The dopamine metabolite 5,6-dihydroxyindole (DHI) binds directly to the Nurr1 LBD within a non-canonical pocket, forming a covalent adduct with Cys566, and stimulates Nurr1 transcriptional activity including target genes underlying dopamine homeostasis.\",\n      \"method\": \"X-ray crystallography, biophysical binding assays, cell-based reporter assays, zebrafish model\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure, covalent adduct confirmed, functional validation in cells and zebrafish\",\n      \"pmids\": [\"30853418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The canonical ligand-binding pocket of Nurr1 LBD, although collapsed in crystal structures, is dynamic and exchanges between conformations on the microsecond-to-millisecond timescale, with high solvent accessibility that permits binding of unsaturated fatty acids.\",\n      \"method\": \"Solution NMR spectroscopy, hydrogen/deuterium exchange mass spectrometry, molecular dynamics simulations\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple biophysical methods including NMR, HDX-MS, and MD simulations convergently defining LBP dynamics\",\n      \"pmids\": [\"30416039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The Nurr1 LBD lacks a canonical co-activator-binding site but possesses an alternative hydrophobic surface on the opposite side from the classical site; site-directed mutagenesis of this region abolished or altered transcriptional activity, and Nurr1 LBD activity correlates with proteasome-dependent degradation.\",\n      \"method\": \"Crystal structure analysis, site-directed mutagenesis, transcriptional reporter assays, proteasome inhibitor experiments\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — structural analysis combined with mutagenesis and functional assays identifying a novel co-activator interaction surface\",\n      \"pmids\": [\"17032747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Structural and biochemical analyses of NR4A2 DNA-binding domain (DBD) bound to Nur-responsive elements (NurREs) at 2.6-2.8 Å resolution revealed that two NR4A2-DBD molecules form a novel dimer interface on an inverted repeat element, and mutation of the interfacial residue V298K or DNA bases involved in the interaction abolished dimerization.\",\n      \"method\": \"X-ray crystallography, mutagenesis, biochemical DNA-binding assays, bioinformatics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with mutagenesis validation defining the molecular basis of NR4A2 dimerization on DNA\",\n      \"pmids\": [\"31723028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nr4a2 directly binds regulatory regions of the Foxp3 locus and mediates permissive histone modifications, inducing Foxp3 expression and Treg differentiation; Nr4a2 deletion in T cells attenuates Treg induction and causes aberrant Th1 induction.\",\n      \"method\": \"ChIP, ectopic expression, siRNA knockdown, conditional T cell-specific knockout mice, in vitro suppression assays, colitis model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirming direct binding, genetic knockout with defined cellular phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"21468021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NR4A2 augments promoter activities of IL-17 and IFN-γ genes in pathogenic T cells, and siRNA-mediated knockdown of NR4A2 significantly reduces IL-17 and IFN-γ production and attenuates the ability of encephalitogenic T cells to transfer EAE.\",\n      \"method\": \"Promoter-luciferase reporter assays, forced expression, siRNA knockdown, EAE adoptive transfer model\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reporter assays plus in vivo adoptive transfer experiments with defined mechanistic readout\",\n      \"pmids\": [\"18550828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NR4A2 controls full Th17 differentiation via autocrine IL-21 signaling; NR4A2 knockdown prevents IL-17 and IL-21 production and reduces IL-23R expression, and the differentiation defect is rescued by exogenous IL-21.\",\n      \"method\": \"siRNA knockdown, in vitro Th17 differentiation assays, cytokine rescue experiments, in vivo siRNA treatment in EAE model\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistatic rescue experiment plus in vivo validation placing NR4A2 upstream of IL-21 autocrine loop in Th17 differentiation\",\n      \"pmids\": [\"23437182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Nurr1 directly regulates dopamine synthesis and storage in MN9D dopamine cells by increasing expression of aromatic L-amino acid decarboxylase (AADC) and vesicular monoamine transporter-2 (VMAT2); VMAT2 upregulation requires continuous Nurr1 expression, and AADC and VMAT2 are deregulated in midbrain DA cells of Nurr1 knockout embryos.\",\n      \"method\": \"Inducible Nurr1 cell line, DA content measurement, in situ hybridization in knockout embryos\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible expression system combined with knockout validation demonstrating direct instructive role\",\n      \"pmids\": [\"12915123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Nurr1 directly transactivates the osteocalcin (Ocn) gene in osteoblasts by binding as a monomer to an NBRE-like site in the proximal Ocn promoter; endogenous Nurr1 binds this site in chromatin immunoprecipitation assays, and mutation of the NBRE-like site abolishes Nurr1-dependent promoter activation.\",\n      \"method\": \"EMSA, ChIP, luciferase reporter assays with deletion/mutation analysis, adenoviral Nurr1 overexpression in primary osteoblasts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — EMSA, ChIP, and mutagenesis converging on direct transcriptional activation\",\n      \"pmids\": [\"15485875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Nurr1 directly regulates Pitx3 expression in dopaminergic neurons by binding to a non-canonical NBRE consensus sequence 5' of the Pitx3 gene; deletion of this sequence abolishes Nurr1-driven reporter expression, and direct Nurr1-Pitx3 promoter interaction was confirmed in dopaminergic cell cultures and embryonic midbrain tissue by ChIP.\",\n      \"method\": \"Reporter assays with deletion/mutation analysis, ChIP in cell cultures and embryonic tissue, dose-dependent overexpression\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP in vivo plus mutagenesis of binding site demonstrating direct regulation\",\n      \"pmids\": [\"22363463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Nurr1 regulates RET expression in adult rat midbrain dopaminergic neurons; adeno-associated vector-delivered anti-Nurr1 ribozyme knockdown reduces RET mRNA by ~77% and RET protein by ~47% in the substantia nigra; Nurr1 induces RET promoter transcription in a cell-type and concentration-dependent manner independent of NBRE elements.\",\n      \"method\": \"AAV-delivered ribozyme knockdown in vivo, qRT-PCR, microdialysis, reporter assays in cell lines\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo knockdown with mRNA and protein measurements, plus promoter reporter assays; single lab study\",\n      \"pmids\": [\"20533997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nurr1 interacts with p53 and represses its transcriptional assembly and activity in an interaction-dependent, dose-dependent manner; Nurr1 overexpression decreases Bax expression and protects cells from doxorubicin-induced apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays, siRNA knockdown, overexpression, apoptosis assays\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP demonstrating interaction plus functional reporter and apoptosis assays; single lab study\",\n      \"pmids\": [\"19671681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NR4A2 (Nurr1) transcriptionally activates arginase 1 expression by directly binding to its promoter in macrophages, and NR4A2 expression induced by TLR ligands (via PI3K-Akt signaling) promotes alternative (M2) macrophage polarization.\",\n      \"method\": \"ChIP, luciferase reporter assays, forced expression, siRNA knockdown, flow cytometry, adoptive transfer sepsis model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirming direct promoter binding plus in vivo adoptive transfer with defined mechanistic pathway\",\n      \"pmids\": [\"25953901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PTH increases Nurr1 mRNA/protein levels prior to FGF23 induction; Nurr1 is essential for PTH-mediated FGF23 transcription and binds directly to functional Nurr1 binding sites in the FGF23 promoter as confirmed by ChIP in osteoblast-like cells.\",\n      \"method\": \"ChIP, luciferase reporter assays, siRNA knockdown, in vivo CKD rat model, immunohistochemistry\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirming direct promoter binding, siRNA knockdown, and in vivo validation in disease model\",\n      \"pmids\": [\"24940803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NR4A2 directly transactivates the proximal MMP-13 promoter via its DNA binding domain; NR4A2 overexpression in synoviocytes promotes proliferation, survival, anchorage-independent growth, migration, and invasion; a DNA-binding domain point mutation abolishes MMP-13 transcriptional activation.\",\n      \"method\": \"Stable overexpression, lentiviral shRNA knockdown, luciferase reporter assays with mutation analysis, proliferation and invasion assays\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis of DNA-binding domain combined with multiple functional assays clearly placing NR4A2 as direct MMP-13 transactivator\",\n      \"pmids\": [\"22275273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PGE2-induced NR4A2 increases fatty acid oxidation in colorectal cancer cells by inducing multiple FAO pathway genes via direct binding to Nur77-binding response elements (NBREs) in their regulatory regions, with concomitant recruitment of transcriptional coactivators.\",\n      \"method\": \"ChIP, NBRE reporter assays, siRNA knockdown, metabolic assays (fatty acid oxidation)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP confirming direct NBRE binding plus coactivator recruitment and metabolic readout\",\n      \"pmids\": [\"21757690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Nurr1 transcriptionally regulates alpha-synuclein expression; decreased Nurr1 expression increases alpha-synuclein transcription, establishing Nurr1 as a transcriptional repressor of alpha-synuclein.\",\n      \"method\": \"Nurr1 overexpression and knockdown with mRNA level measurement, transcriptional assays\",\n      \"journal\": \"Neuroreport\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, expression-based readout without ChIP or promoter mutagenesis\",\n      \"pmids\": [\"18463503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Multiple splice variants of Nurr1 (nurr1a, nurr1b, nurr1c, TINUR, nurr2, nurr2c) are produced by alternative RNA splicing in dopamine neurons; variants nurr1a, nurr1b, nurr1c, and TINUR have significantly reduced transcriptional activity compared with full-length Nurr1, while nurr2 and nurr2c act as dominant negatives.\",\n      \"method\": \"RT-PCR, sequencing, transfection-based transcriptional reporter assays in dopaminergic SK-N-AS cells\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple isoforms characterized by sequencing and functional reporter assays; single lab\",\n      \"pmids\": [\"16313515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Nurr1 directly inhibits p21 (Waf1/Cip1) gene transcription by binding to the p21 promoter in a p53-independent manner, thereby promoting G1-S progression and intestinal epithelial cell proliferation after ischemia/reperfusion injury.\",\n      \"method\": \"ChIP, luciferase reporter assays with deletion/mutation analysis, siRNA knockdown, overexpression, cell cycle analysis\",\n      \"journal\": \"Journal of molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP confirming direct binding, promoter mutagenesis, and gain/loss-of-function with cell cycle readout\",\n      \"pmids\": [\"27553040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nr4a2 is downstream of Brn3a in the developing habenula and mediates expression of a subset of Brn3a-regulated transcripts; Nr4a2 is expressed in a subset of habenular neurons and is required for their proper differentiation as shown by microarray analysis in Brn3a null embryos.\",\n      \"method\": \"Microarray analysis of Brn3a null embryos, in situ hybridization, genetic epistasis analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via knockout combined with genome-wide expression profiling; single lab\",\n      \"pmids\": [\"19906978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nr4a2 is necessary and sufficient for specification of GABAergic amacrine cell subtype identity in the retina; its targeted inactivation eliminates dopaminergic and p57Kip2+ amacrine cells with a concomitant increase in calbindin+ amacrine cells, and misexpressed Nr4a2 promotes GABAergic AC differentiation.\",\n      \"method\": \"Conditional knockout mice, retroviral misexpression, dominant-negative construct, immunostaining\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function and gain-of-function with defined cellular phenotypes demonstrating necessity and sufficiency\",\n      \"pmids\": [\"19692620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Three missense mutations in exon 3 of NURR1 identified in schizophrenic and manic-depressive patients each cause a ~30-40% reduction in in vitro transcriptional activity of NURR1 dimers.\",\n      \"method\": \"Direct sequencing, in vitro transcriptional activity assays with mutant constructs\",\n      \"journal\": \"American journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional reporter assays demonstrating transcriptional deficit; single lab\",\n      \"pmids\": [\"11121187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The lncRNA LUCAT1 controls splicing and stability of NR4A2 mRNA by interacting with heterogeneous nuclear ribonucleoproteins (hnRNP C, M, A2B1); cells lacking LUCAT1 show altered NR4A2 splicing, reduced and delayed NR4A2 expression, and elevated inflammatory gene expression.\",\n      \"method\": \"CHIRP-MS (comprehensive identification of RNA-binding proteins by mass spectrometry), RNA immunoprecipitation, RNA-seq, LPS stimulation with LUCAT1 KO\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — proteomic identification of binding partners plus RNA-seq and functional gene expression readout; multiple orthogonal methods\",\n      \"pmids\": [\"36577072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Nurr1 binds directly to consensus binding sites in the U3 region of the HIV LTR and recruits the CoREST/HDAC1/G9a/EZH2 repressor complex, suppressing HIV transcription in microglial cells; mutation of the Nurr1 DNA-binding domain blocks HIV suppression.\",\n      \"method\": \"ChIP, Nurr1 overexpression and knockdown, DNA-binding domain mutagenesis, transcriptomics in human microglial cells and iPSC-derived microglia\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct LTR binding, mutagenesis of DBD, CoREST complex recruitment confirmed in multiple microglial cell types\",\n      \"pmids\": [\"35797416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Nurr1 and Foxa2 physically interact and synergistically protect midbrain dopaminergic neurons against toxic insults both cell-autonomously (in mDA neurons) and in a paracrine mode (via forced expression in neighboring glia); combined AAV-mediated delivery of both factors markedly protected mDA neurons for at least 1 year in a PD mouse model.\",\n      \"method\": \"Co-immunoprecipitation, AAV-mediated gene delivery in PD mouse model, primary cell culture protection assays\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP demonstrating interaction plus in vivo gene therapy validation; single lab\",\n      \"pmids\": [\"25759364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Nurr1 directly binds to the RasGRP1 intron and regulates RasGRP1 expression; RasGRP1 in turn regulates the Ras-Raf-MEK-ERK signaling cascade in LPS-induced inflammation in microglia, providing a novel mechanism of Nurr1's anti-inflammatory function.\",\n      \"method\": \"ChIP-seq in LPS-stimulated BV2 cells, ChIP validation, siRNA knockdown, ERK pathway analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide ChIP-seq with targeted validation identifying direct binding site plus downstream pathway dissection\",\n      \"pmids\": [\"32612143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Nurr1 expression is regulated by neural activity through voltage-dependent calcium channels (VDCCs) and calcineurin in hippocampal and cortical neurons; calcineurin but not CaMK is critical for activity-dependent Nurr1 induction.\",\n      \"method\": \"Pharmacological inhibitors of VDCCs and calcineurin/CaMK, KCl/bicuculline/tetrodotoxin manipulations, Western blot/mRNA measurement\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — pharmacological dissection of upstream regulatory pathway; single lab, no genetic validation\",\n      \"pmids\": [\"24291696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Amodiaquine, chloroquine, and cytosporone B bind directly to the Nurr1 LBD as confirmed by protein NMR structural footprinting; many other reported NR4A-active ligands do not bind Nurr1 LBD and show Nurr1-independent transcriptional effects.\",\n      \"method\": \"Protein NMR structural footprinting, transcriptional reporter assays with Nurr1-dependent and Nurr1-independent readouts\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structural footprinting directly confirming ligand-LBD interaction, distinguishing binders from non-binders\",\n      \"pmids\": [\"33289551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Nurr1 agonists (chloroquinolineamine analogs) activate Nurr1 transcriptional activity as monomer, homodimer, and heterodimer, and induce robust recruitment of NCoR1 and NCoR2 co-regulators to the Nurr1 LBD while promoting Nurr1 dimerization.\",\n      \"method\": \"TR-FRET co-regulator recruitment assays, dimerization assays, cellular reporter assays with response elements, gene expression in human astrocytes\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical co-regulator recruitment and dimerization assays; single lab study\",\n      \"pmids\": [\"33629841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Chloroquine activates Nurr1 function by two distinct mechanisms: direct binding to Nurr1's LBD to promote transcriptional activity, and upregulation of Nurr1 expression through the CREB signaling pathway; CQ activates TREG differentiation and Foxp3 expression in a Nurr1-dependent manner.\",\n      \"method\": \"Ligand-binding assays (LBD), reporter assays, siRNA and conditional knockout, in vivo IBD model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — binding assay plus Nurr1-dependent functional rescue; single lab\",\n      \"pmids\": [\"31664129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NR4A2 (Nurr1) NF-κB transrepression in astrocytes involves nuclear-specific inhibition of p65 binding at inflammatory gene promoters without preventing p65 nuclear translocation; combined RNAi knockdown of Nur77 and Nurr1 abolishes the anti-inflammatory effect of C-DIM5.\",\n      \"method\": \"ChIP-seq, quantitative PCR arrays, nuclear/cytoplasmic fractionation, siRNA combined knockdown, MPTP mouse astrocyte model\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq revealing nuclear mechanism, genetic epistasis via combined knockdown, multiple orthogonal methods\",\n      \"pmids\": [\"30111648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NR4A2 suppresses CCR5 gene transcription by binding directly to its promoter in macrophages, and NR4A2 overexpression induces M2 macrophage polarization, protecting cardiomyocytes from high glucose-induced damage; this protective effect is blocked by CCR5 re-expression.\",\n      \"method\": \"Bioinformatic prediction, luciferase reporter assays, NR4A2 overexpression in vivo and in vitro, co-culture, flow cytometry\",\n      \"journal\": \"Microvascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reporter assay for direct binding, epistatic rescue experiment; single lab, no ChIP\",\n      \"pmids\": [\"34774582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"α-Synuclein overexpression (WT or A53T) reduces Nurr1 transcription by modulating the NF-κB binding site region (-605 to -418 bp) of the Nurr1 promoter; α-SYN downregulates NF-κB expression and decreases NF-κB binding to the Nurr1 promoter without affecting mRNA stability.\",\n      \"method\": \"Reporter assays with promoter deletion constructs, ChIP for NF-κB at Nurr1 promoter, mRNA stability assays, overexpression in cell lines\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and promoter deletion analysis identifying the regulatory mechanism; single lab\",\n      \"pmids\": [\"32477062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-409-3p directly targets Nr4a2 (validated by luciferase reporter assay); reduced Nr4a2 activates the NF-κB pathway, promoting microglial migration and activation; exosomal miR-409-3p from activated mast cells is transferred to microglia to mediate this effect.\",\n      \"method\": \"Luciferase 3'UTR reporter assay, Western blot for Nr4a2 and NF-κB, Transwell migration assays, fluorescent exosome transfer\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — luciferase validation of miRNA target plus functional downstream NF-κB pathway analysis; single lab\",\n      \"pmids\": [\"33750404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NR4A2 is part of a p53-miR-34 regulatory network: p53 activates endogenous miR-34 which suppresses NR4A2 through a validated miR-34 recognition element in the NR4A2 3'UTR; conversely, NR4A2 overexpression blocks p53 target gene induction including miR-34a, creating a feedback loop.\",\n      \"method\": \"3'UTR reporter screen, miRNA recognition element mapping and mutagenesis, miR-34 overexpression, p53 pathway activation, cell proliferation assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — validated 3'UTR element by mutagenesis, bidirectional feedback demonstrated; single lab\",\n      \"pmids\": [\"27121375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NR4A2 directly transactivates CDK4 gene expression by binding to the CDK4 promoter region, facilitating gastric cancer cell proliferation; H. pylori induces NR4A2 via the PI3K/AKT-Sp1 pathway, and Sp1 binds the Nurr1 promoter to activate its transcription.\",\n      \"method\": \"ChIP, luciferase reporter assays, siRNA knockdown and overexpression, in vivo xenograft\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct CDK4 promoter binding plus in vivo validation; single lab\",\n      \"pmids\": [\"32114387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NR4A2 promotes cytoprotective autophagy in pancreatic cancer cells via transcriptional regulation of ATG7 and ATG12; gemcitabine induces NR4A2 expression and the NR4A2-ATG7/ATG12 axis is required for gemcitabine-induced drug resistance.\",\n      \"method\": \"RNA-seq with CRISPR/Cas9 KO, KEGG pathway analysis, NR4A2 knockdown/overexpression, drug resistance assays\",\n      \"journal\": \"Cancer research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA-seq with CRISPR KO identifying ATG7/ATG12 as direct targets; single lab, no ChIP validation\",\n      \"pmids\": [\"35582016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NR4A2 transcriptional activity represses the TSP-1 promoter in synoviocytes independent of DNA binding; ectopic NR4A2 expression reduces TSP-1 mRNA/protein with concomitant increases in VEGF and IL-8; depletion of NR4A2 shifts the TSP-1/VEGF expression ratio.\",\n      \"method\": \"Promoter-luciferase assays with deletion analysis, stable NR4A2 overexpression and shRNA knockdown, ELISA, qRT-PCR\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — promoter deletion analysis and reciprocal gain/loss of function; single lab, mechanism of DNA-binding independence established by reporter assays\",\n      \"pmids\": [\"23933487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FoxM1 directly promotes Nurr1 transcription by binding to the Nurr1 promoter; FoxM1 inhibition downregulates Nurr1 expression and Ki-67, and FoxM1 overexpression promotes intestinal epithelial cell proliferation after hypoxia/reperfusion via Nurr1 activation.\",\n      \"method\": \"ChIP, luciferase reporter assays, siRNA knockdown, forced expression, in vivo I/R rat model\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirming direct FoxM1 binding to Nurr1 promoter plus in vivo model; single lab\",\n      \"pmids\": [\"31704909\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NR4A2/Nurr1 is a ligand-regulated orphan nuclear receptor transcription factor that binds DNA as a monomer (at NBRE elements), homodimer, or RXR heterodimer to transactivate dopaminergic neuron target genes (TH, DAT, VMAT2, AADC, RET, Pitx3, CDK4, VIP, osteocalcin) and repress inflammatory genes (via docking to NF-κB p65 and recruiting the CoREST/HDAC1/G9a/EZH2 repressor complex); its LBD contains a dynamic non-canonical ligand-binding pocket where endogenous prostaglandins (PGE1/PGA1) and dopamine metabolite DHI form covalent adducts with Cys566 to activate transcription, while synthetic chloroquine-scaffold compounds and NSAIDs modulate its activity bidirectionally through LBD binding and distinct co-regulator (NCoR1/2) recruitment patterns, and its expression is itself regulated by neural activity (via VDCC-calcineurin), NF-κB, CREB, FoxM1, miR-34, and miR-409-3p.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NR4A2 (Nurr1) is an orphan nuclear receptor transcription factor that functions as a master regulator of midbrain dopaminergic neuron identity and a signal-dependent modulator of inflammatory gene expression across multiple immune and neural cell types. It binds DNA as a monomer at NBRE elements or as a homodimer on NurRE inverted repeats to directly transactivate dopaminergic genes (TH, AADC, VMAT2, RET, Pitx3), cell-cycle regulators (CDK4, p21), and metabolic targets (osteocalcin, FAO genes, arginase 1, FGF23), while also repressing inflammatory gene transcription by docking to NF-κB p65 on target promoters and recruiting the CoREST/HDAC1/G9a/EZH2 corepressor complex [PMID:19345186, PMID:12915123, PMID:31723028, PMID:25953901]. Although originally classified as a ligand-independent receptor due to a collapsed canonical ligand-binding pocket, its LBD is conformationally dynamic and accommodates endogenous ligands—prostaglandin A1 and the dopamine metabolite 5,6-dihydroxyindole—that form covalent adducts with Cys566, inducing activation-function helix repositioning and transcriptional activation [PMID:32451509, PMID:30853418, PMID:30416039]. Beyond the nervous system, NR4A2 drives Foxp3 expression and regulatory T cell differentiation, promotes Th17 polarization via an IL-21 autocrine loop, and directs M2 macrophage polarization through arginase 1 induction, placing it at the interface of adaptive and innate immunity [PMID:21468021, PMID:23437182, PMID:25953901].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that NR4A2 coding variants found in psychiatric patients reduce transcriptional activity provided the first evidence that diminished Nurr1 function has pathological consequences beyond dopamine neuron specification.\",\n      \"evidence\": \"Direct sequencing of schizophrenia/manic-depression patients with in vitro reporter assays of mutant constructs\",\n      \"pmids\": [\"11121187\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cohort; causality not established by family segregation or rescue\", \"No structural basis for how exon 3 mutations reduce dimer activity\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating that Nurr1 directly induces AADC and VMAT2 in dopaminergic cells—and that these genes are deregulated in Nurr1 knockout embryos—established Nurr1 as an instructive transcription factor for the full dopamine biosynthesis and storage program, not just TH alone.\",\n      \"evidence\": \"Inducible Nurr1 cell line with DA content measurement; in situ hybridization in Nurr1 KO embryos\",\n      \"pmids\": [\"12915123\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target repertoire not yet defined\", \"Whether Nurr1 binds AADC/VMAT2 promoters directly was not shown by ChIP at this stage\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identifying that Nurr1 monomers bind an NBRE-like element in the osteocalcin promoter demonstrated that Nurr1 functions as a direct transcriptional activator outside the nervous system.\",\n      \"evidence\": \"EMSA, ChIP, and mutagenesis in primary osteoblasts\",\n      \"pmids\": [\"15485875\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of Nurr1 in bone homeostasis not fully delineated\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Crystallographic analysis revealing a collapsed canonical ligand pocket with an alternative hydrophobic co-activator surface on the LBD explained how Nurr1 could be constitutively active yet still regulatable, resolving its classification as an 'orphan' receptor.\",\n      \"evidence\": \"Crystal structure analysis, site-directed mutagenesis, proteasome inhibitor experiments\",\n      \"pmids\": [\"17032747\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endogenous ligands exist was unresolved\", \"Identity of co-activators recruited to the alternative surface unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showing that NR4A2 augments IL-17 and IFN-γ promoter activity in pathogenic T cells and is required for encephalitogenic T cell function revealed a pro-inflammatory role for Nurr1 in adaptive immunity, distinct from its neurotrophic identity.\",\n      \"evidence\": \"Reporter assays plus EAE adoptive transfer model\",\n      \"pmids\": [\"18550828\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct promoter binding not confirmed by ChIP\", \"Mechanism distinguishing activating vs. repressive NR4A2 function in T cells vs. myeloid cells unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The discovery that Nurr1 docks onto NF-κB p65 at inflammatory gene promoters and recruits the CoREST corepressor complex to clear p65 provided the molecular mechanism for signal-dependent transrepression, explaining how Nurr1 protects dopaminergic neurons from neuroinflammation.\",\n      \"evidence\": \"ChIP, Co-IP, reporter assays, siRNA, conditional knockout mice in microglia/astrocytes\",\n      \"pmids\": [\"19345186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the CoREST-dependent mechanism operates in non-CNS inflammatory contexts was unknown\", \"Post-translational modifications governing p65-docking were not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Genetic loss- and gain-of-function studies showing Nr4a2 is necessary and sufficient for GABAergic amacrine cell specification in the retina expanded its role beyond midbrain DA neurons to a general neuronal subtype selector.\",\n      \"evidence\": \"Conditional knockout and retroviral misexpression in mouse retina\",\n      \"pmids\": [\"19692620\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets in amacrine cells not identified\", \"Whether Nr4a2 coordinates with the same co-regulators as in DA neurons unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that Nr4a2 directly binds the Foxp3 locus and mediates permissive histone modifications established it as a key inducer of regulatory T cell differentiation, bridging its immune roles from purely pro-inflammatory (Th17) to immunosuppressive (Treg).\",\n      \"evidence\": \"ChIP, conditional T cell–specific KO, in vitro suppression assays, colitis model\",\n      \"pmids\": [\"21468021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the same factor drives both Th17 and Treg programs in different contexts was unresolved\", \"Signals specifying the switch not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"ChIP-based identification that PGE2-induced NR4A2 binds NBREs in fatty acid oxidation gene regulatory regions linked NR4A2 to metabolic reprogramming in colorectal cancer cells.\",\n      \"evidence\": \"ChIP, NBRE reporter assays, siRNA knockdown, metabolic assays\",\n      \"pmids\": [\"21757690\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NR4A2 regulation of FAO is a general metabolic function or cancer-specific unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placing NR4A2 upstream of the IL-21 autocrine loop in Th17 differentiation—with rescue by exogenous IL-21—resolved the epistatic position of NR4A2 in the Th17 program.\",\n      \"evidence\": \"siRNA knockdown, cytokine rescue, in vivo EAE siRNA treatment\",\n      \"pmids\": [\"23437182\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NR4A2 directly binds IL-21 regulatory regions not confirmed by ChIP\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"NMR and HDX-MS revealed that the Nurr1 LBD pocket, though collapsed in crystals, is dynamically accessible on microsecond-to-millisecond timescales and can accommodate unsaturated fatty acids, overturning the view that the pocket is permanently occluded.\",\n      \"evidence\": \"Solution NMR, HDX-MS, molecular dynamics simulations\",\n      \"pmids\": [\"30416039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of endogenous high-affinity ligands still unknown at this point\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Crystal structures of DHI covalently bound to Cys566 in the Nurr1 LBD identified the first endogenous ligand for Nurr1—a dopamine metabolite—establishing a feedback mechanism linking dopamine catabolism to transcriptional maintenance of DA neuron identity.\",\n      \"evidence\": \"X-ray crystallography, biophysical binding assays, reporter assays, zebrafish model\",\n      \"pmids\": [\"30853418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological concentrations of DHI in the brain and whether they reach activating levels not determined\", \"Whether DHI activates Nurr1 in non-dopaminergic cells unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Crystal structures of the NR4A2 DBD dimer on NurRE DNA at 2.6–2.8 Å resolution defined the structural basis for homodimerization on inverted repeat elements, explaining how Nurr1 achieves diverse DNA-binding modes (monomer vs. dimer).\",\n      \"evidence\": \"X-ray crystallography with mutagenesis (V298K) and biochemical DNA-binding assays\",\n      \"pmids\": [\"31723028\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length structure including LBD-DBD communication not resolved\", \"Heterodimer structure with RXR not determined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The crystal structure of PGA1 covalently adducted to Cys566 with a 21° shift of helix H12 provided the first high-resolution activation mechanism for Nurr1, showing that prostaglandin metabolites are bona fide endogenous agonists.\",\n      \"evidence\": \"2.05 Å X-ray crystallography, mutagenesis, cell-based and in vivo MPTP model validation\",\n      \"pmids\": [\"32451509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PGA1 or PGE1 reaches sufficient concentrations in the brain niche\", \"Structural basis for inverse agonism or antagonism not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"NMR structural footprinting discriminating true LBD-binding ligands (amodiaquine, chloroquine) from non-binders among reported NR4A modulators clarified the pharmacological landscape and showed that many published 'Nurr1 agonists' act through Nurr1-independent mechanisms.\",\n      \"evidence\": \"Protein NMR footprinting, Nurr1-dependent and -independent reporter assays\",\n      \"pmids\": [\"33289551\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding mode and co-crystal structure of chloroquine-class compounds not yet determined\", \"In vivo selectivity profiles of validated LBD binders incomplete\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating that Nurr1 directly binds the HIV LTR and recruits the CoREST/HDAC1/G9a/EZH2 complex to silence HIV transcription in microglia extended the CoREST-dependent transrepression paradigm from inflammatory genes to viral latency maintenance.\",\n      \"evidence\": \"ChIP, DBD mutagenesis, transcriptomics in human microglial cells and iPSC-derived microglia\",\n      \"pmids\": [\"35797416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Nurr1-mediated HIV silencing operates in other CNS reservoir cells (astrocytes, perivascular macrophages) unknown\", \"Contribution relative to other latency-maintaining factors not quantified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of the lncRNA LUCAT1 as a post-transcriptional regulator that controls NR4A2 mRNA splicing and stability via hnRNPs revealed a new layer of NR4A2 regulation that links lncRNA biology to inflammatory gene control.\",\n      \"evidence\": \"CHIRP-MS, RNA immunoprecipitation, RNA-seq in LUCAT1 KO cells\",\n      \"pmids\": [\"36577072\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LUCAT1-dependent splicing produces functionally distinct NR4A2 isoforms with altered activity\", \"In vivo relevance of LUCAT1-NR4A2 axis in inflammation not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for how NR4A2 switches between transcriptional activation and CoREST-dependent transrepression in different cellular contexts; the full-length structure encompassing LBD-DBD allosteric communication; and the physiological ligand concentrations of DHI and prostaglandins in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length NR4A2 structure available\", \"Context-dependent switch between activation and repression mechanistically unresolved\", \"In vivo ligand occupancy not measured\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 6, 7, 9, 10, 11, 14, 15, 16, 17, 20, 25, 37]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 10, 11, 15, 17, 25, 27]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 13, 32]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 5, 10, 25, 32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [0, 6, 9, 10, 11, 14, 15, 16, 17, 20, 25, 27, 37]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 6, 7, 8, 14, 32, 33, 35]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [13, 27, 34, 36]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [9, 21, 22]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [9, 12, 28]}\n    ],\n    \"complexes\": [\n      \"CoREST/HDAC1/G9a/EZH2 corepressor complex\"\n    ],\n    \"partners\": [\n      \"NFKB1 (p65/RelA)\",\n      \"FOXA2\",\n      \"TP53\",\n      \"NCOR1\",\n      \"NCOR2\",\n      \"RCOR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}